SIGNATUREFD, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$670,238
-2.3%
43,325
-0.8%
0.02%
-5.6%
Q2 2023$686,150
-3.5%
43,676
+1.2%
0.02%
-5.3%
Q1 2023$711,161
+59.3%
43,153
+50.8%
0.02%
+46.2%
Q4 2022$446,394
-2.5%
28,615
-18.9%
0.01%
-18.8%
Q3 2022$458,000
+33.9%
35,303
+45.1%
0.02%
+33.3%
Q2 2022$342,000
-31.9%
24,331
-30.6%
0.01%
-20.0%
Q1 2022$502,000
+67.3%
35,051
+59.3%
0.02%
+66.7%
Q4 2021$300,000
-23.5%
21,999
-8.2%
0.01%
-35.7%
Q3 2021$392,000
+22.1%
23,956
+25.8%
0.01%
+7.7%
Q2 2021$321,000
-2.7%
19,049
+5.3%
0.01%
-13.3%
Q1 2021$330,000
+12.6%
18,098
+12.5%
0.02%
+7.1%
Q4 2020$293,000
+11.8%
16,080
+9.4%
0.01%0.0%
Q3 2020$262,000
+6.5%
14,698
+6.9%
0.01%
-6.7%
Q2 2020$246,000
+24.9%
13,747
+6.0%
0.02%
-11.8%
Q1 2020$197,000
-43.1%
12,969
-26.0%
0.02%
-34.6%
Q4 2019$346,000
+41.8%
17,536
+23.6%
0.03%
+30.0%
Q3 2019$244,000
+86.3%
14,185
+92.3%
0.02%
+81.8%
Q2 2019$131,000
-51.3%
7,375
-44.2%
0.01%
-52.2%
Q1 2019$269,000
+2888.9%
13,206
+2391.7%
0.02%
+2200.0%
Q4 2018$9,0005300.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders